Improving breast cancer diagnosis in low-income countries using advanced imaging techniques.
Breast core-needle diagnostics in LMICs via millifluidics and direct-to-digital imaging: development and validation in Ghana
This study is working on a new, easy-to-use system to help doctors in low- and middle-income countries quickly and accurately diagnose breast cancer using advanced technology, so patients can get the right treatment sooner.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10881871 on NIH RePORTER |
What this research studies
This research focuses on enhancing breast cancer diagnosis in low- and middle-income countries by developing a new automated system that combines innovative technologies. It utilizes a millifluidics approach for handling core needle biopsies and a direct-to-digital imaging solution to produce high-quality histopathology images quickly and affordably. The goal is to provide timely and accurate diagnoses, which are crucial for effective treatment planning. Additionally, the project aims to implement AI tools for patient triage and local diagnostic support.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in low- and middle-income countries who are undergoing evaluation for breast cancer.
Not a fit: Patients outside of low- and middle-income countries or those not requiring breast cancer diagnostics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the speed and accuracy of breast cancer diagnoses in resource-limited settings, potentially saving lives.
How similar studies have performed: Similar approaches have shown promise in improving diagnostic techniques in resource-limited settings, indicating potential for success in this novel application.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Levenson, Richard M. — University of California at Davis
- Study coordinator: Levenson, Richard M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.